{"id":403844,"date":"2020-12-21T11:03:09","date_gmt":"2020-12-21T16:03:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403844"},"modified":"2020-12-21T11:03:09","modified_gmt":"2020-12-21T16:03:09","slug":"ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/","title":{"rendered":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care\n<\/li>\n<li>\nThe objective is affordable, rapid mass testing by analyzing saliva samples and allowing digital results to be uploaded to a medical cloud\n<\/li>\n<li>\nInnovative approach using ams spectral sensors to enable test results which are easy to read and conclusive\n<\/li>\n<li>\nInitial results, on inactivated virus particles, indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons\n<\/li>\n<\/ul>\n<p>PREMSTAETTEN, Austria &amp; GUELPH, Canada&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nToday, ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, and Precision Biomonitoring, a Canadian-based leader in virus detection tools, announce a global partnership to share technologies to develop an innovative testing device for the Covid-19 (SARS-CoV-2) virus. The partnership will see ams\u2019 innovative spectral sensor technology paired with Precision Biomonitoring\u2019s lateral flow and digital capabilities. The combination is expected to re-imagine mass testing devices for Covid-19 (SARS-CoV-2). Initial results, on inactivated virus particles, indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons.\n<\/p>\n<p>\n\u201cThe pandemic is still with us and will continue to be part of our lives well into the new year. This partnership with ams will continue to provide innovative solutions urgently needed by government and authorities to help track and control this virus,\u201d says Dr. Mario Thomas, CEO, Precision Biomonitoring. \u201cWe are dedicated to developing quality testing devices and with the addition of this highly-sensitive technology we will continue to change the testing landscape.\u201d\n<\/p>\n<p>\nTo create innovative solutions and support pandemic control, ams and Precision Biomonitoring are investigating the efficacy and sensitivity of a lab-free lateral-flow test connected to a medical cloud, to detect virus particles in as little as around 15-minutes. The test is focused on detecting the virus at earlier stages of infection, before symptoms have appeared.\n<\/p>\n<p>\nThe ams spectral sensor solution allows fluorescence-based read out of antigen detection, strengthening ams\u2019 leadership in delivering high-quality professional health diagnostics, designed to improve speed and reliability of rapid, point-of-care diagnostics.\n<\/p>\n<p>\n\u201cGovernments and authorities need to enable fast, reliable and effective testing. Our initial results for this solution indicate that even asymptomatic patients who carry the virus could be more readily identified. We expect the combination of Precision Biomonitoring and ams technology to become an essential tool in the effort to help control the pandemic and resume the many economic and social activities that comprise what we call <i>normal life<\/i>,\u201d says Jennifer Zhao, Executive Vice President, division Advanced Optical Sensors, ams. \u201cThis is aided by the fact that, once approved, the testing solution can be produced inexpensively and without complex limitations at high scale. We hope that this solution will eliminate complicated logistics and clinical processes and streamline approaches to mass testing.\u201d\n<\/p>\n<p>\nFor more information about ams spectral sensing, please see <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fams.com%2Ftechnology%2Fspectral-sensing%2520&amp;esheet=52351815&amp;newsitemid=20201221005298&amp;lan=en-US&amp;anchor=https%3A%2F%2Fams.com%2Ftechnology%2Fspectral-sensing&amp;index=1&amp;md5=c453ab9225d6e90e3452811032859623\">https:\/\/ams.com\/technology\/spectral-sensing<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201221005298\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201221005298\/en\/<\/a><\/span><\/p>\n<p>\nAmy Fl\u00e9cher<br \/>\n<br \/>ams AG<br \/>\n<br \/>VP Marketing Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:press@ams.com\">press@ams.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ams.com&amp;esheet=52351815&amp;newsitemid=20201221005298&amp;lan=en-US&amp;anchor=ams.com&amp;index=2&amp;md5=ed3a7870f5cd4e635dc605480bf832a8\">ams.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Austria Europe North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Infectious Diseases Biotechnology Health Medical Devices<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201221005298\/en\/566087\/3\/ams_Sensing_is_Life_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) The easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care The objective is affordable, rapid mass testing by analyzing saliva samples and allowing digital results to be uploaded to a medical cloud Innovative approach using ams spectral sensors to enable test results which are easy to read and conclusive Initial results, on inactivated virus particles, indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons PREMSTAETTEN, Austria &amp; GUELPH, Canada&#8211;(BUSINESS WIRE)&#8211; Today, ams (SIX: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403844","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) The easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care The objective is affordable, rapid mass testing by analyzing saliva samples and allowing digital results to be uploaded to a medical cloud Innovative approach using ams spectral sensors to enable test results which are easy to read and conclusive Initial results, on inactivated virus particles, indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons PREMSTAETTEN, Austria &amp; GUELPH, Canada&#8211;(BUSINESS WIRE)&#8211; Today, ams (SIX: &hellip; Continue reading &quot;ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T16:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)\",\"datePublished\":\"2020-12-21T16:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/\"},\"wordCount\":577,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/\",\"name\":\"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-21T16:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/","og_locale":"en_US","og_type":"article","og_title":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk","og_description":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) The easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care The objective is affordable, rapid mass testing by analyzing saliva samples and allowing digital results to be uploaded to a medical cloud Innovative approach using ams spectral sensors to enable test results which are easy to read and conclusive Initial results, on inactivated virus particles, indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons PREMSTAETTEN, Austria &amp; GUELPH, Canada&#8211;(BUSINESS WIRE)&#8211; Today, ams (SIX: &hellip; Continue reading \"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-21T16:03:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)","datePublished":"2020-12-21T16:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/"},"wordCount":577,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/","name":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-21T16:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201221005298r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ams-and-precision-biomonitoring-announce-global-partnership-to-enable-pandemic-control-through-the-development-of-a-rapid-saliva-antigen-testing-device-for-covid-19-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403844"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403844\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}